FOLFOX treatment response prediction in metastatic or recurrent colorectal cancer patients via machine learning algorithms

Early identification of metastatic or recurrent colorectal cancer (CRC) patients who will be sensitive to FOLFOX (5‐FU, leucovorin and oxaliplatin) therapy is very important. We performed microarray meta‐analysis to identify differentially expressed genes (DEGs) between FOLFOX responders and nonresp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Wei, Fu, Dongliang, Kong, Xiangxing, Huang, Zhiheng, Hwang, Maxwell, Zhu, Yingshuang, Chen, Liubo, Jiang, Kai, Li, Xinlin, Wu, Yihua, Li, Jun, Yuan, Ying, Ding, Kefeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013065/
https://www.ncbi.nlm.nih.gov/pubmed/31893575
http://dx.doi.org/10.1002/cam4.2786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013065/
https://www.ncbi.nlm.nih.gov/pubmed/31893575
http://dx.doi.org/10.1002/cam4.2786

Ejemplares similares